000 | 03133cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223032457.0 | ||
008 | 191210s2019 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.08.09.Ph.D.2019.Be.P | ||
100 | 0 | _aBerween Mahmoud Abdelelgawad Elmahmoudy | |
245 | 1 | 4 |
_aThe possible protective effects of DDP4 (dipeptidylpeptidase-4) inhibitors and pyrrolidine dithiocarbamate in thioacetamide-induced ulcerative colitis in rats / _cBerween Mahmoud Abdelelgawad Elmahmoudy ; Supervised Mohamed Farrag Elyamany , Laila Ahmed Rashed , Mai Ahmed Galal |
246 | 1 | 5 | _aالدور الوقائى الممكن لمثبطات دايى بيبتيدال وبيروليدين داى ثايو كربامات فى تقرح القالون المستحدث بالثيواسيتاميد بالجرذان |
260 |
_aCairo : _bBerween Mahmoud Abdelelgawad Elmahmoudy , _c2019 |
||
300 |
_a191 P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology | ||
520 | _aBackground: Ulcerative colitis (UC) is a disease related to a combination of genetic and environmental factors, associated with overproduction of both ROS and RNSleading to oxidative and nitrosative stress, as well as release of pro-inflammatory cytokines. Methods: The effect of sulfasalzine, pyrrolidine dithiocarbamate (PDTC) and saxagliptin was evaluated in thioacetamide (TAA)-induced UC model in the current study.Animals were treated orally with vehicle, sulfasalazine (500 mg/kg), PDTC (100 mg/kg), and saxagliptin (10 mg/kg) for two weeks,UC was induced by single intrarectal instillation of TAA at day eight. Colon samples were collected to assess colonic content of phosphorylated extraregular signal translated kinases (PERK), mitogen-activated protein kinase (MAPK), cAMP response element-binding protein (CREB), Interleukin (IL)-12, Caspase-3, Ý-defensin, glucagon like peptide (GLP)-1,inducible nitric oxide synthase (iNOS), as well as to perform histopathological investigations. Results:TAA-treated rats experienced increases in colon mass index, ulcerative area, colonic PERK, MAPK, CREB, caspase-3, IL-12,Ý-defensin, iNOS, together with decreases in body weight, colon mass index, ulcerative area and GLP-1 and distortion of colonic architecture, as shown by histopathological examination. PDTC and saxagliptin attenuated the severity of colitis, as demonstrated by decrease in body weight loss, colon mass index, ulcerative area as well as decrease in colonic PERK, MAPK, CREB, caspase-3, IL-12,Ý-defensin and iNOS | ||
530 | _aIssued also as CD | ||
653 | 4 | _aInflammatory mediators | |
653 | 4 | _aOxidative stress | |
653 | 4 | _aUlcerative colitis | |
700 | 0 |
_aLaila Ahmed Rashed , _eSupervisor |
|
700 | 0 |
_aMai Ahmed Galal , _eSupervisor |
|
700 | 0 |
_aMohamed Farrag Elyamany , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aShimaa _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c75794 _d75794 |